Skywell Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 11.89%
- Profit Growth -3.18%
- Ebitda 2125.87%
- Net Worth 48.55%
- Total Assets 23.60%
About Skywell Healthcare
Skywell Healthcare Private Limited (SHPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 February 2017 (Seven years and 11 months 27 days old ). Its registered office is in Kurukshetra, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aman Gupta and Sahil Gupta serve as directors at the Company.
Company Details
- Location
Kurukshetra, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304HR2017PTC067918
- Company No.
067918
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Skywell Healthcare Private Limited offer?
Skywell Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Allergic Drug, Common Disease Medicines, Pharmaceutical Capsules, Nutraceuticals & Dietary Supplements, Protein Powder, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil.
Who are the key members and board of directors at Skywell Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aman Gupta  | Director | 28-Feb-2017 | Current |
| Sahil Gupta | Director | 28-Feb-2017 | Current |
Financial Performance of Skywell Healthcare.
Skywell Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.89% increase. The company also saw a slight decrease in profitability, with a 3.18% decrease in profit. The company's net worth Soared by an impressive increase of 48.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skywell Healthcare?
In 2021, Skywell Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skywell Healthcare?
Unlock and access historical data on people associated with Skywell Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skywell Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skywell Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.